Greenwich LifeSciences Income Statement (2019-2025) | GLSI

Income Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating items
Research & Development (Quarter)
0.60M0.28M0.56M0.66M2.06M1.66M0.63M1.72M2.46M1.83M1.38M2.16M2.33M2.19M2.31M2.29M6.16M2.60M3.51M3.52M
Selling, General & Administrative (Quarter)
0.55M0.32M0.20M0.21M0.31M0.33M0.14M0.66M0.44M0.41M0.37M0.34M0.50M0.34M0.35M0.44M1.93M0.68M0.54M0.65M
Operating Expenses (Quarter)
1.15M0.60M0.75M0.87M2.38M1.99M0.77M2.38M2.89M2.24M1.75M2.50M2.84M2.54M2.66M2.73M8.08M3.28M4.05M4.17M
Operating Income (Quarter)
-1.15M-0.60M-0.75M-0.87M-2.38M-1.99M-0.77M-2.38M-2.89M-2.24M-1.75M-2.50M-2.84M-2.54M-2.66M-2.73M-8.08M-3.28M-4.05M-4.17M
EBIT (Quarter)
-1.15M-0.60M-0.75M-0.87M-2.38M-1.99M-0.77M-2.38M-2.89M-2.24M-1.75M-2.50M-2.84M-2.54M-2.66M-2.73M-8.08M-3.28M-4.05M-4.17M
Non-operating items
Interest & Investment Income (Quarter)
0.00M0.00M0.00M0.02M0.02M0.03M0.06M0.10M0.12M0.12M0.11M0.09M0.06M0.05M0.06M0.04M0.02M0.02M0.02M
Net income details
EBT (Quarter)
-1.15M-0.60M-0.75M-0.86M-2.36M-1.97M-0.75M-2.32M-2.79M-2.12M-1.63M-2.39M-2.75M-2.47M-2.61M-2.67M-8.04M-3.26M-4.03M-4.15M
Profit After Tax (Quarter)
-1.15M-0.60M-0.75M-0.86M-2.36M-1.97M-0.75M-2.32M-2.79M-2.12M-1.63M-2.39M-2.75M-2.47M-2.61M-2.67M-8.04M-3.26M-4.03M-4.15M
Income from Continuing Operations (Quarter)
-1.15M-0.60M-0.75M-0.86M-2.36M-1.97M-0.75M-2.32M-2.79M-2.12M-1.63M-2.39M-2.75M-2.47M-2.61M-2.67M-8.04M-3.26M-4.03M-4.15M
Consolidated Net Income (Quarter)
-1.15M-0.60M-0.75M-0.86M-2.36M-1.97M-0.75M-2.32M-2.79M-2.12M-1.63M-2.39M-2.75M-2.47M-2.61M-2.67M-8.04M-3.26M-4.03M-4.15M
Income towards Parent Company (Quarter)
-1.15M-0.60M-0.75M-0.86M-2.36M-1.97M-0.75M-2.32M-2.79M-2.12M-1.63M-2.39M-2.75M-2.47M-2.61M-2.67M-8.04M-3.26M-4.03M-4.15M
Net Income towards Common Stockholders (Quarter)
-1.15M-0.60M-0.75M-0.86M-2.36M-1.97M-0.75M-2.32M-2.79M-2.12M-1.63M-2.39M-2.75M-2.47M-2.61M-2.67M-8.04M-3.26M-4.03M-4.15M
Additional items
EPS (Basic) (Quarter)
-0.12-0.05-0.06-0.07-0.18-0.15-0.06-0.18-0.22-0.17-0.13-0.19-0.21-0.19-0.20-0.20-0.61-0.25-0.30-0.30
EPS (Weighted Average and Diluted) (Quarter)
-0.06-0.18-0.22-0.17-0.13-0.19-0.21-0.19-0.20-0.20-0.61-0.25-0.30-0.30
Shares Outstanding (Weighted Average) (Quarter)
9.50M12.80M12.79M12.97M0.02M13.06M12.92M12.82M12.91M12.85M12.85M12.85M0.02M12.86M12.88M12.97M13.01M13.17M13.27M13.40M
Shares Outstanding (Diluted Average) (Quarter)
12.92M12.82M12.91M12.85M12.85M12.85M12.85M12.86M12.91M13.14M13.01M13.17M13.37M13.64M
EBITDA (Quarter)
-1.15M-0.60M-0.75M-0.87M-2.38M-1.99M-0.77M-2.38M-2.89M-2.24M-1.75M-2.50M-2.84M-2.54M-2.66M-2.73M-8.08M-3.28M-4.05M-4.17M
Shares Outstanding (Quarter)
12.70M12.85M12.92M12.99M13.15M12.95M12.77M12.85M12.85M12.85M12.85M12.85M12.85M12.88M13.07M13.14M13.15M13.19M13.47M13.79M